The MiniPDX™ model showed that MDA-MB-231 cells overexpressing miR-638 were more susceptible to 5-FU treatment in vivo....Overall, our findings uncovered a novel role for miR-638 in the regulation of 5-FU chemosensitivity in BC patients. miR-638 may serve as a potential biomarker for NAC response in patients with BC.